Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» protein degradation
protein degradation
10 clinical trials to watch in the first half of 2025
BioPharma Dive
Thu, 01/2/25 - 11:42 am
clinical trials
Eli Lilly
cardiovascular disease
Arvinas
protein degradation
Vera Therapeutics
IgA nephropathy
Novarts
pelacarsen
Entyvio
IBD
Novo Nordisk
Alzheimer's disease
Beam Therapeutics
sickle cell disease
COMPASS Pathways
psychedelics
Moderna Therapeutics
Verve Therapeutics
high cholesterol
Biogen buys in to molecular glues with Neomorph deal worth up to $1.45B
Fierce Biotech
Wed, 10/30/24 - 08:45 pm
Biogen
Neomorph
molecular glue
protein degradation
Pharma’s ‘it’ therapy — a new drug class gaining steam
Pharma Voice
Wed, 09/4/24 - 11:30 am
protein degradation
Arvinas
Merck KGaA
Sanofi
Pfizer
Novartis
Biohaven Tumbles After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump
Investors Business Daily
Wed, 05/29/24 - 09:27 pm
Biohaven
immune disease
protein degradation
BHV-1300
immune disorders
Novartis pays $150M for Arvinas' phase 3-ready prostate cancer protein degrader
Fierce Biotech
Thu, 04/11/24 - 11:56 am
Novartis
Arvinas
protein degradation
prostate cancer
Gilead dives deeper into Nurix protein degrader collab, paying $15M for 2-year extension
Fierce Biotech
Tue, 04/2/24 - 11:38 am
Gilead Sciences
Nurix Therapeutics
protein degradation
Firefly Bio assembles with $94M and an ADC dream team to work on protein degraders
Fierce Biotech
Thu, 02/15/24 - 11:23 am
Firefly Bio
protein degradation
Merck offers up to $610M for one of C4’s protein degraders
Fierce Biotech
Tue, 12/12/23 - 11:07 am
Merck
C4 Therapeutics
protein degradation
Kymera’s protein degrader starts Phase II trial in atopic dermatitis
Clinical Trials Arena
Fri, 12/8/23 - 11:05 am
Kymera
Sanofi
protein degradation
clinical trials
atopic dermatitis
KT-474
Roche pays $50M upfront to Monte Rosa in molecular glue deal
Fierce Biotech
Tue, 10/17/23 - 09:46 pm
Roche
molecular glue
Monte Rosa
QuEEN
protein degradation
Nurix and Seagen Collaborate on Breakthrough Cancer Therapeutics
Globe Newswire
Thu, 09/7/23 - 10:57 am
Nurix Therapeutics
Seagen
protein degradation
cancer
antibody-drug conjugate
Astellas notches another protein degrader pact with $21M upfront for PeptiDream
Fierce Biotech
Tue, 07/25/23 - 10:08 am
Astellas
protein degradation
PeptiDream
Astellas delves deeper into protein degrading drugs with Cullgen deal
BioPharma Dive
Thu, 06/15/23 - 09:55 am
Astellas
Cullgen
protein degradation
Proxygen, averaging a new collab every 10 months, sticks $2.5B molecular glue deal with Merck
Fierce Biotech
Wed, 04/5/23 - 10:09 am
Merck
Proxygen
molecular glue
protein degradation
At EpiBiologics, a pair of Genentech alumni wants to make next-gen protein degraders
BioPharma Dive
Wed, 03/22/23 - 10:07 am
Genentech
EpiBiologics
protein degradation
First Protein Degrader Tested Outside Oncology Yields Promising Results
BioSpace
Wed, 12/14/22 - 07:23 pm
Kymera Therapeutics
Sanofi
protein degradation
hidradenitis suppurativa
atopic dermatitis
KT-474
Pfizer's $1B protein degradation bet yields 3% response rate in Arvinas' midphase breast cancer trial
Fierce Biotech
Tue, 11/22/22 - 11:00 am
Pfizer
protein degradation
Arvinas
clinical trials
breast cancer
ARV-471
Merck KGaA Strikes $550M Deal with Proxygen in Latest Protein Degradation Deal
BioSpace
Fri, 06/3/22 - 10:29 am
Merck KGaA
Proxygen
protein degradation
Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership in Protein Degradation
Yahoo/Accesswire
Tue, 05/10/22 - 10:29 pm
Evotec
Bristol Myers Squibb
protein degradation
Plexium nabs $102M for protein degradation work weeks after $500M Amgen tie-up
Fierce Biotech
Wed, 02/23/22 - 10:34 am
Plexium
Amgen
protein degradation
venture capital
funding
Pages
1
2
next ›
last »